Skip to main content
. Author manuscript; available in PMC: 2012 Sep 24.
Published in final edited form as: Peptides. 2010 Aug 24;31(11):2067–2074. doi: 10.1016/j.peptides.2010.07.012

Fig. 4.

Fig. 4

Representative M-mode images in response to hRFRP-1 and saline (control) on mouse heart. Intravenous administration of hRFRP-1 at 5 μmols/kg bw (n = 5) resulted in acute and dramatic effects on heart function (Fig. 4A = pre-injection; Fig. 4B = 5 minutes post-injection). Composite results for echocardiographic studies are shown in Table 5. However, saline (n = 4) did not result in dramatic changes in cardiac function (Fig. 4C = pre-injection; Fig. 4D = 5 minutes post-injection). Data were analyzed using 1-way ANOVA followed by a Dunnett's Multiple Comparison Test with p < 0.05 considered a statistically significant difference from control (*; Table 5).